RESUMO
INTRODUCTION: Biofilm in chronic wounds impedes the wound healing process. Each biofilm has differing characteristics requiring a multifaceted approach for removal while maintaining a surrounding environment conducive to wound healing. OBJECTIVE: In this study, 3 of the components in a wound cleanser are tested to determine synergy in eradicating biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa in vitro. MATERIALS AND METHODS: The 3 components assessed for synergy were ethylenediamine tetraacetic acid sodium salts (EDTA), vicinal diols (VD; ethylhexylglycerin and octane-1,2-diol), and polyhexamethylene biguanide (PHMB). Each component was assessed individually and in combination while dissolved in a base solution. The Calgary assay method was used for biofilm growth and treatment. Kull Equation analysis for synergy was conducted using viable count results. RESULTS: Synergy is defined as the interaction of components to produce a combined effect greater than the sum of their separate effects. The base solution containing all 3 components (EDTA, VD, and PHMB) reduced biofilm viability by more than 5 logs, demonstrating statistically significant synergy. The 3 components tested individually in the base solution resulted in the following: EDTA did not reduce bacteria viability; VD reduced viability by about 1 log; and PHMB reduced P aeruginosa viability by about 2.5 logs and MRSA viability by about 4 logs. Of importance, the MRSA biofilm failed to regrow in the recovery plates after combined treatment, indicating complete elimination of the biofilm bacteria. CONCLUSIONS: The experimental and calculated results indicate the 3 components (VD, EDTA, and PHMB) when used together act synergistically to eradicate MRSA and P aeruginosa biofilms in vitro.
Assuntos
Biguanidas/uso terapêutico , Biofilmes/efeitos dos fármacos , Detergentes/uso terapêutico , Ácido Edético/uso terapêutico , Éteres de Glicerila/uso terapêutico , Octanóis/uso terapêutico , Pele/efeitos dos fármacos , Ferimentos e Lesões/tratamento farmacológico , Biguanidas/administração & dosagem , Detergentes/administração & dosagem , Sinergismo Farmacológico , Ácido Edético/administração & dosagem , Éteres de Glicerila/administração & dosagem , Humanos , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Octanóis/administração & dosagem , Pseudomonas aeruginosa/efeitos dos fármacos , Pele/microbiologia , Ferimentos e Lesões/microbiologiaRESUMO
In Barth syndrome (BTHS) mutations in tafazzin leads to changes in both the quantities and the molecular species of cardiolipin (CL), which are the hallmarks of BTHS. Contrary to the well-established alterations in CL associated with BTHS; recently a marked decrease in the plasmalogen levels in Barth specimens has been identified. To restore the plasmalogen levels, the present study reports the effect of promotion of plasmalogen biosynthesis on the lipidome of lymphoblasts derived from Barth patients as well as on cell viability, mitochondria biogenesis, and mitochondrial membrane potential. High resolution 31P NMR phospholipidomic analysis showed an increase in the levels of plasmenylethanolamine (the major plasmalogen in lymphoblasts), which reached values comparable to the control and a compensatory decrease in the levels of its diacyl-PE counterpart. Importantly, 31P NMR showed a significant increase in the levels of CL, while not altering the levels of monolysocardiolipin. Mass spectrometry measurements showed that the promotion of plasmalogen biosynthesis did not change the molecular species profile of targeted phospholipids. In addition, promotion of plasmalogen biosynthesis did not impact on cellular viability, although it significantly decrease mitochondria copy number and restored mitochondrial membrane potential. Overall, the results showed the efficacy of the promotion of plasmalogen biosynthesis on increasing the CL levels in a BTHS cell model and highlight the potential beneficial effect of a diet supplemented with plasmalogen precursors to BTHS patients.
Assuntos
Síndrome de Barth/metabolismo , Cardiolipinas/metabolismo , Éteres de Glicerila/metabolismo , Linfócitos/metabolismo , Lisofosfolipídeos/metabolismo , Plasmalogênios/biossíntese , Aciltransferases , Síndrome de Barth/sangue , Síndrome de Barth/dietoterapia , Síndrome de Barth/genética , Cardiolipinas/análise , Sobrevivência Celular , Células Cultivadas , Criança , Pré-Escolar , Gorduras na Dieta , Suplementos Nutricionais , Éteres de Glicerila/administração & dosagem , Humanos , Lactente , Mutação com Perda de Função , Linfócitos/citologia , Lisofosfolipídeos/análise , Masculino , Potencial da Membrana Mitocondrial , Mitocôndrias/metabolismo , Biogênese de Organelas , Cultura Primária de Células , Fatores de Transcrição/genéticaRESUMO
Novel liquid crystal nanoparticles (LCNs) composed of isostearyl glyceryl ether (GE-IS) and ethoxylated hydrogenated castor oil (HCO-60) were developed for the enhanced transdermal delivery of 4-biphenyl acetic acid (BAA). The physical properties and pharmaceutical properties of the LCNs were measured. The interaction between the intercellular lipid model of the stratum corneum and the LCNs was observed to elucidate the skin permeation mechanism. In the formulation, the LCNs form niosomes with mean particles sizes of 180-300 nm. The skin absorption mechanisms of LCNs are different, depending upon the application and buffer concentration. The LCNs composed of GE-IS and HCO-60 are attractive tools for use as transdermal drug delivery systems carriers for medicines and cosmetics, due to their high efficiency and safety.
Assuntos
Sistemas de Liberação de Medicamentos , Éteres de Glicerila/administração & dosagem , Cristais Líquidos , Nanopartículas/administração & dosagem , Fenilacetatos/administração & dosagem , Administração Cutânea , Animais , Óleo de Rícino/administração & dosagem , Óleo de Rícino/química , Liberação Controlada de Fármacos , Éteres de Glicerila/química , Humanos , Técnicas In Vitro , Cristais Líquidos/química , Masculino , Camundongos Pelados , Nanopartículas/química , Fenilacetatos/química , Pele/metabolismo , Absorção Cutânea , Testes de Irritação da PeleRESUMO
Scandinavian folk medicine used shark liver oil for the treatment of cancers and other ailments based on the rarity of tumors in sharks and their ability to resist infections. Shark liver oil is a source of alkylglycerols which have been studied as anti-cancer agents in several clinical trials. Moreover, alkylglycerols have been investigated for the treatment of radiation induced side effects and for their ability to boost the immune system. Several experimental studies have shown the ability of alkylglycerols to open the blood brain barrier to facilitate the access of therapeutic drugs to the central nervous system. This review covers the most important studies of alkylglycerols in both animals and humans.
Assuntos
Antineoplásicos/uso terapêutico , Óleos de Peixe/uso terapêutico , Glicerol/análogos & derivados , Glicerol/uso terapêutico , Éteres de Glicerila/uso terapêutico , Sistema Imunitário/efeitos dos fármacos , Neoplasias/tratamento farmacológico , Animais , Antineoplásicos/química , Antineoplásicos/imunologia , Barreira Hematoencefálica/efeitos dos fármacos , Ensaios Clínicos como Assunto , Óleos de Peixe/química , Óleos de Peixe/imunologia , Glicerol/administração & dosagem , Glicerol/química , Éteres de Glicerila/administração & dosagem , Éteres de Glicerila/química , Humanos , Neoplasias/radioterapia , Lesões por Radiação/prevenção & controle , Tubarões , Esqualeno/uso terapêuticoRESUMO
Biological properties of a lipid preparation based on the liver of a schoolmaster gonate squid Berryteuthis magister was studied on a group of Wistar male rats with experimental cardioangiopathy model. The preparation containing 10% polyunsaturated fatty acids and 50% alkyl-diacylglycerides ("Magister-Oil" nutritional additive) exhibits (i) a lipid-correction effect (manifested by a decrease in the levels of triglycerides and cholesterol of the atherogenic lipoprotein fraction and by an increase in the level of cholesterol of a high-density lipoprotein fraction); (ii) immunomodulant effect (manifested by activation of the phagocyte neutrophil link); and (iii) stimulation of the erythro- and lymphopoiesis. The obtained results allow the "Magister-Oil" nutritional additive to be recommended as a means of prophylaxis and treatment of disorders accompanied by disturbances in lipid metabolism, immunity system, and peripheral blood parameters.